Document Detail

Lipid management in patients with diabetes mellitus.
MedLine Citation:
PMID:  16098840     Owner:  NLM     Status:  MEDLINE    
The prevalence of diabetes mellitus has been increasing dramatically in recent decades. This trend closely follows the marked increase in the prevalence of obesity in the United States. As the proportion of the population with diabetes increases, the need for prevention and therapy to reduce cardiovascular events in these patients becomes critically important. Although plasma glucose control is important in reducing microvascular complications due to diabetes, lipid management is essential in these patients to reduce the incidence of cardiovascular events. Adult patients with type 2 diabetes, in the absence of known coronary artery disease (CAD), have a similar 10-year risk for cardiac events as do patients without diabetes with established coronary disease. Recent clinical trials have highlighted the importance of aggressive plasma lipid lowering for both the primary and secondary prevention of atherosclerotic events in patients with diabetes. The likelihood of an ever-increasing diabetic patient population requires new systematic approaches to prevention as well as therapy for these patients and further development of a team approach by the medical community to optimize care despite limited resources.
Alan S Brown
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of cardiology     Volume:  96     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-15     Completed Date:  2005-09-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  26E-32E     Citation Subset:  AIM; IM    
Midwest Heart Disease Prevention Center, Naperville, Illinois, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antilipemic Agents / therapeutic use*
Blood Glucose / metabolism
Cardiovascular Diseases / prevention & control
Clinical Trials as Topic
Diabetes Mellitus, Type 2 / drug therapy*,  epidemiology,  prevention & control*
Hyperlipidemias / blood,  diet therapy,  drug therapy,  therapy*
Lipids / blood*
Obesity / complications,  epidemiology,  prevention & control
United States / epidemiology
Reg. No./Substance:
0/Antilipemic Agents; 0/Blood Glucose; 0/Lipids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Management of dyslipidemia in patients with complicated metabolic syndrome.
Next Document:  Rationale for new American Diabetes Association Guidelines: are national cholesterol education progr...